Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) October 10, 2017 Abiomed Second Quarter Fiscal 2018 Earnings and Conference Call Notification September 20, 2017 Abiomed Receives FDA PMA Approval for Impella RP® for Right Heart Failure August 28, 2017 Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant July 27, 2017 Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year July 6, 2017 Abiomed First Quarter Fiscal 2018 Earnings and Conference Call Notification June 30, 2017 New Study with Abiomed's Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery June 9, 2017 Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology May 30, 2017 Abiomed to Present at the Jefferies Healthcare Conference May 9, 2017 Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017 May 4, 2017 Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study May 4, 2017 Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year April 13, 2017 Abiomed Fourth Quarter Fiscal 2017 Earnings and Conference Call Notification March 30, 2017 Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts March 19, 2017 First-Ever Presentation on Abiomed's Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific Session March 16, 2017 Abiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations … 10 11 12 13 …